Skip to the content
  • Our Company
    • Management Team
    • Board Members
    • Events
  • Our Approach
  • Partner
  • Careers
  • Resources
  • News
Menu
  • Our Company
    • Management Team
    • Board Members
    • Events
  • Our Approach
  • Partner
  • Careers
  • Resources
  • News
  • Contact
Menu
  • Contact

Dr. Jigar Patel, CEO of Nimble Therapeutics, speaks at BIO-Europe® 2019 in Hamburg

read more
Path 3
  • Conference
  • December 4, 2019

Dr. Jigar Patel, CEO of Nimble Therapeutics, speaks at BIO-Europe® 2019 in Hamburg about the spin-out last April of Nimble from Roche to accelerate the development and discovery of peptide-based therapeutics, and make this technology available to other pharma companies.

PreviousRNA Transcription and Splicing Errors as a Source of Cancer Frameshift Neoantigens for Vaccines.
NextIdentification of immunoreactive linear epitopes of Borrelia miyamotoi.
PreviousRNA Transcription and Splicing Errors as a Source of Cancer Frameshift Neoantigens for Vaccines.
NextIdentification of immunoreactive linear epitopes of Borrelia miyamotoi.
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact

603 Science Dr
Madison, WI, USA 53711

LinkedIn
  • Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech
    Read More